Cernostics Revenue and Competitors
Estimated Revenue & Valuation
- Cernostics's estimated annual revenue is currently $140k per year.
- Cernostics's estimated revenue per employee is $70,000
Employee Data
- Cernostics has 2 Employees.
- Cernostics grew their employee count by -33% last year.
Cernostics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Marketing | Reveal Email/Phone |
2 | Sales Representative | Reveal Email/Phone |
Cernostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.5M | 7 | -36% | N/A | N/A |
#2 | $0.8M | 10 | -9% | N/A | N/A |
#3 | $5.6M | 50 | -19% | N/A | N/A |
#4 | $1.6M | 19 | -5% | N/A | N/A |
#5 | $0.6M | 9 | -25% | N/A | N/A |
#6 | $0.5M | 7 | -36% | N/A | N/A |
#7 | $1.3M | 16 | -24% | N/A | N/A |
#8 | $0.6M | 9 | -55% | N/A | N/A |
#9 | $6.9M | 55 | 10% | N/A | N/A |
#10 | $0.1M | 2 | -33% | N/A | N/A |
What Is Cernostics?
Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types. Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Learn more about our technology platform [www.cernostics.com] and how it will change the future of cancer diagnostics.
keywords:N/AN/A
Total Funding
2
Number of Employees
$140k
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cernostics News
It's space that will combine wet lab space and office, and will enable Castle to expand the local operations of Cernostics Inc. a startup...
The dermatology business has an estimated addressable market of nearly $2 billion, and the TissueCypher test from the Cernostics acquisition...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 2 | -33% | N/A |
#2 | N/A | 2 | -94% | N/A |
#3 | $0.1M | 2 | 0% | N/A |
#4 | $0.2M | 2 | -33% | N/A |
#5 | $7.5M | 2 | -33% | N/A |